Lymphodepleting chemotherapy trials for Lung cancer

All Lymphodepleting chemotherapy trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Lymphodepleting chemotherapy for Lung cancer

• Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
  NCT07480213 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
  NCT07744256 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
  NCT07467863 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Lymphodepleting chemotherapy for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.